Skip to content

Acupuncture and Chinese Herbal Medicine to improve live birth rate of in vitro fertilization: a randomized controlled trial

Acupuncture and Chinese Herbal Medicine to improve live birth rate of in vitro fertilization: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003267
Enrollment
Unknown
Registered
2020-05-01
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

in vitro fertilization - embryo transfer

Interventions

Sponsors

The First Affiliated Hospital, Heilongjiang University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Women >= 20 to 1 year; 4. Undergoing IVF with an intention of fresh ET on day 3 or 5.

Exclusion criteria

Exclusion criteria: 1. Women with an intention to replace frozen embryos only. 2. Preimplantation genetic testing. 3. History of recurrent miscarriages defined as having three consecutive miscarriages. 4. Having acupuncture or CHM for infertility within 3 months prior the IVF. 5. Women with abnormal liver or renal function tests.

Design outcomes

Primary

MeasureTime frame
Live birth;

Secondary

MeasureTime frame
Cumulative live birth rate within 6 months after randomization;Patient acceptability of acupuncture to be measured at the end of the intervention.;Miscarriage rate;Side effects;Congenital abnormalities;Physical growth parameters and neurological development of children up to 3 years of age;Changes in markers of stress, anxiety and HRQoL;Implantation rate;Ongoing pregnancy rate (=8 weeks);Ectopic pregnancy rate;Embryo quality;Positive serum hCG level (2 weeks after ET);Multiple pregnancy rate;Cost effectiveness analyses (after the interim analysis);Pregnancy complications;

Countries

China

Contacts

Public ContactXiaoke Wu

The First Affiliated Hospital, Heilongjiang University of Chinese Medicine

xiaokewu2002@vip.sina.com+86 13796025599

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026